Quantitative evaluation of the interventional effect of estrogen on Alzheimer disease

Chinese Journal of Clinical Rehabilitation

Volumn 10, Issue 30, 2006, Pages 37-39

  Zhang, Yan Xia ^a   Luo, Gang ^a   Guo, Zong Jun ^b   Cui, Rui Yao ^b   Wang, Li Qun ^a   Zhou, Cui Ling ^a  

^a 88 Hospital of Chinese PLA   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PLACEBO; THIAMINE;

ADULT; AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTICLE; CHINA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SUBSTITUTION; EDUCATION; FEMALE; HUMAN; INTELLIGENCE TEST; MENOPAUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS; RATING SCALE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; VALIDATION PROCESS;

EID: 33747322138     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chinese source. 1996,10(3):97
2. Wevers A,Burghaus L,Moser N,et al. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches.Behav Brain Res 2000;113(1-2):207-15
3. Miller MM, Monjam AA, Buckholtz NS. Estrogen replacement therapy for the potential treatment or prevention of Alzheimer's disease. Ann NY Acad Sci 2001; 949:223-34
4. Lloyd GK,Williams M. Neuronal nicotinic acetylcholine receptors as novel drug targets.J Pharmacol Exp Ther 2000;292(2):461-7
5. Simpkins JW, Green PS, Gridley KE, et al. Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease. Am J Med 2000;103(3A):19S-25S
6. Waring SC, Rocca WA, Petersen RC ,et al. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 1999;52(5):965-70
7. Kawas C,Resnich S,Morruson A,et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.Neurology 1997;48(6):1517-21
8. Chinese source. 2001,34(4):254
9. Kawas C ,Resnich S, Morruson A ,et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 1997;48(6):1517-21
10. Brenner DE,Kukull WA,Stergachis A.Postmenopausal estrogen replcement therapy and risk of Alzheimer disease.A population -based case control study. Am J Epidemiol 1994;140(3):262-7
11. Tang MX,Jacobs D,Stern Y,et al.Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease.Lancet 2001;348:429-32
12. Burkman RT,Collins JA,Greene RA.Current perspectives on benefits and risk of hormone replacement therapy.Am J Obstet Gynecol 2001;185 (2 suppl):13-23
13. Chinese source. 2003,7(10):1538-9
14. Zandi PP,Carlson MC,Plassman BL,et al.Hormone replacement therapy and incidence of Alzheimer disease in older women:the Cache County Study.JAMA 2002;288(17):2123-9
15. Zhao XZ,Wang W,Kang ZH,et al.The relation between the learning and memory disturbance and changes of the hippocampal synaptic interface structural parameters in vascular cementic rats.Xiandai Kangfu(Morden Rehabil)2001;5 (6):54-5
16. Daniel JM,Dohanich GP. Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J Neurosci 2001;21(17):6949
17. Chinese source. 2002,6(17):2550-1